Viral envelope glycoproteins promote viral infection by mediating the fusio
n of the viral membrane with the host-cell membrane. Structural and biochem
ical studies of two viral glycoproteins, influenza hemagglutinin and HIV-1
envelope protein, have led to a common model for viral entry. The fusion me
chanism involves a transient conformational species that can be targeted by
therapeutic strategies. This mechanism of infectivity is likely utilized b
y a wide variety of enveloped viruses for which similar therapeutic interve
ntions should be possible.